| |
|
|
Amie Franklin, PhD |
| Dr. Franklin has been a member of EGB Advisors LLC since its founding and has contributed to the establishment of its first portfolio company Inverseon. Prior to entering the biopharmaceutical industry, Dr. Franklin was a postdoctoral researcher at the University of California campuses in Berkeley and San Francisco. Dr. Franklin earned her Ph.D. in biological sciences from Stanford University and holds a B.S. degree from the University of California, Berkeley. |
|
|
|
